Alterations of NMDA receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats

References

• Jacobs SA, Tsien JZ. Genetic overexpression of NR2B subunit enhances social recognition memory for different strains and species. PLoS One 2012;7(4):e36387.
   Web of Science ®Google Scholar
• Foster TC. Dissecting the age-related decline on spatial learning and memory tasks in rodent models: N-methyl-d-aspartate receptors and voltage-dependent Ca2 +channels in senescent synaptic plasticity. Prog Neurobiol 2012;96(3):283–303.
   PubMed Web of Science ®Google Scholar
• Shi L, Adams MM, Linville MC, Caloric restriction eliminates the aging-related decline in NMDA and AMPA receptor subunits in the rat hippocampus and induces homeostasis. Exp Neurol 2007;206(1):70–9.
   PubMed Web of Science ®Google Scholar
• Janssen WG, Vissavajjhala P, Andrews G, Cellular and synaptic distribution of NR2A and NR2B in macaque monkey and rat hippocampus as visualized with subunit-specific monoclonal antibodies. Exp Neurol 2005;191(Suppl 1):S28–44.
   Google Scholar
• Li XB, Yang ZX, Yang L, Neuroprotective effects of flax lignan against NMDA-induced neurotoxicity in vitro. CNS Neurosci Ther 2012;18(11):927–33.
   PubMed Web of Science ®Google Scholar
• Cevikbas F, Steinhoff M, Ikoma A. Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development. CNS Neurosci Ther 2011;17(6):742–9.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zengin A, Deng C, Li Y, Newell KA, High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: The association with the up-regulation of NMDA receptor binding in the rat brain. Exp Neurol 2009;216(1):132–8.
   PubMed Web of Science ®Google Scholar
• Adams MM, Shi L, Linville MC, Caloric restriction and age affect synaptic proteins in hippocampal CA3 and spatial learning ability. Exp Neurol 2008;211(1):141–9.
   PubMed Web of Science ®Google Scholar
• Proctor DT, Coulson EJ, Dodd PR. Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease. Prog Neurobiol 2011;93(4):509–21.
   PubMed Web of Science ®Google Scholar
• Huang YH, Ishikawa M, Lee BR, Searching for presynaptic NMDA receptors in the nucleus accumbens. J Neurosci 2011;31(50):18453–63.
   PubMed Web of Science ®Google Scholar
• Zhao MG, Toyoda H, Lee YS, Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. Neuron 2005;47(6):859–72.
   PubMed Web of Science ®Google Scholar
• Kang SJ, Liu MG, Chen T, Plasticity of metabotropic glutamate receptor-dependent long-term depression in the anterior cingulate cortex after amputation. J Neurosci 2012; 32(33):11318–29.
   PubMed Web of Science ®Google Scholar
• Nishi A, Watanabe Y, Higashi H, Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades. Proc Natl Acad Sci U S A 2005;102(4):1199–204.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yan J, Zhou P, Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 2012;97(1):1–13.
   PubMed Web of Science ®Google Scholar
• Chen WF, Chang H, Wong CS, Impaired expression of postsynaptic density proteins in the hippocampal CA1 region of rats following perinatal hypoxia. Exp Neurol 2007;204(1):400–10.
   PubMed Web of Science ®Google Scholar
• Hussain N, Flumerfelt BA, Rajakumar N. Glutamatergic regulation of long-term grafts of fetal lateral ganglionic eminence in a rat model of Huntington's disease. Neurobiol Dis 2004;15(3):648–53.
   PubMed Web of Science ®Google Scholar
• Hauber W. Involvement of basal ganglia transmitter systems in movement initiation. Prog Neurobiol 1998;56(5):507–40.
   PubMed Web of Science ®Google Scholar
• Fabbrini G, Brotchie JM, Grandas F, Levodopa-induced dyskinesias. Mov Disord 2007;22(10):1379–89.
   PubMed Web of Science ®Google Scholar
• Hallett PJ, Spoelgen R, Hyman BT, Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking. J Neurosci 2006;26(17):4690–700.
   PubMed Web of Science ®Google Scholar
• Hallett PJ, Standaert DG. Rationale for and use of NMDA receptor antagonists in Parkinson's disease. Pharmacol Ther 2004;102(2):155–74.
   PubMed Web of Science ®Google Scholar
• Errico F, Bonito-Oliva A, Bagetta V, Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate l-DOPA-induced dyskinesia. Exp Neurol 2011;232(2):240–250.
   PubMed Web of Science ®Google Scholar
• Lavoute C, Weiss M, Rostain JC. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis. Exp Neurol 2008;212(1):63–70.
   PubMed Web of Science ®Google Scholar
• Rouillon C, Abraini JH, David HN. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core. Exp Neurol 2008;212(1):213–7.
   PubMed Web of Science ®Google Scholar
• Martella G, Platania P, Vita D, Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial Parkinsonism-linked genes PINK1 or Parkin. Exp Neurol 2009;215(2):388–96.
   PubMed Web of Science ®Google Scholar
• Lester DB, Rogers TD, Blaha CD. Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther 2010;16(3):137–62.
   PubMed Web of Science ®Google Scholar
• Li Y, Huang XF, Deng C, Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats. Synapse 2010;64(3):224–30.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang PH, McLachlan C, Wong PT. Simvastatin reverses the downregulation of dopamine D1 and D2 receptor expression in the prefrontal cortex of 6-hydroxydopamine-induced Parkinsonian rats. Brain Res 2005;1045(1–2):229–33.
   PubMed Web of Science ®Google Scholar
• Warre R, Thiele S, Talwar S, Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of Parkinsonism. Neurobiol Dis 2011;41(3):591–604.
   PubMed Web of Science ®Google Scholar
• Löschmann PA, De Groote C, Smith L, Antiparkinsonian activity of Ro 25–6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease. Exp Neurol 2004;187(1):86–93.
   PubMed Web of Science ®Google Scholar
• Anastasia A, de Erausquin GA, Wojnacki J, Mascó DH. Protection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson's disease. J Neurochem 2007;103(4):1542–52.
   PubMed Web of Science ®Google Scholar
• Yan J, Xu Y, Zhu C, Simvastatin prevents dopaminergic neurodegeneration in experimental Parkinsonian models: the association with anti-inflammatory responses. PLoS One 2011;6(6):e20945.
   PubMed Web of Science ®Google Scholar
• Howard-Jones N. A CIOMS ethical code for animal experimentation. WHO Chron 1985;39:51–6.
   PubMedGoogle Scholar
• Yuan H, Sarre S, Ebinger G, Michotte Y. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease. J Neurosci Methods 2005;144(1):35–45.
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego: Academic Press; 1997.
   Google Scholar
• Aznavour N, Cendres-Bozzi C, Lemoine L, MPTP animal model of Parkinsonism: dopamine cell death or only tyrosine hydroxylase impairment? A study using PET imaging, autoradiography, and immunohistochemistry in the cat. CNS Neurosci Ther 2012;18(11):934–41.
   PubMed Web of Science ®Google Scholar
• Betarbet R, Poisik O, Sherer TB, Greenamyre JT. Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease. Exp Neurol 2004;187(1):76–85.
   PubMed Web of Science ®Google Scholar
• Dunah AW, Wang Y, Yasuda RP, Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-d-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol Pharmacol 2000;57(2):342–52.
   PubMed Web of Science ®Google Scholar
• Greenamyre JT, O'Brien CF. N-methyl-d-aspartate antagonists in the treatment of Parkinson's disease. Arch Neurol 1991;48(9):977–81.
   PubMedGoogle Scholar
• Starr MS. Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse 1995;19(4):264–293.
   PubMed Web of Science ®Google Scholar
• Vernon AC, Zbarsky V, Datla KP, Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo. J Neurochem 2007;103(3):1075–91.
   PubMed Web of Science ®Google Scholar
• Jellinger KA. The pathology of Parkinson's disease. Adv Neurol 2001;86:55–72.
   PubMedGoogle Scholar
• Sgambato-Faure V, Cenci MA. Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease. Prog Neurobiol 2012;96(1):69–86.
   PubMed Web of Science ®Google Scholar
• Kalia LV, Brotchie JM, Fox SH. Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials. Mov Disord 2012;28(2):131–44.
   PubMed Web of Science ®Google Scholar
• Meshul CK, Allen C. Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion. Synapse 2000;36(2):129–42.
   PubMed Web of Science ®Google Scholar
• Maccarrone M, Gubellini P, Bari M, Levodopa treatment reverses endocannabinoid system abnormalities in experimental Parkinsonism. J Neurochem 2003;85(4):1018–1025.
   PubMed Web of Science ®Google Scholar
• He L, Di Monte DA, Langston JW, Quik M. Autoradiographic analysis of N-methyl-d-aspartate receptor binding in monkey brain: effects of 1-methyl-4-phenyl-1,2,3, 6-tetrahy- dropyridine and levodopa treatment. Neuroscience 2000;99(4): 697–704.
   PubMed Web of Science ®Google Scholar
• Fox SH, Brotchie JM, Lang AE. Non-dopaminergic treatments in development for Parkinson's disease. Lancet Neurol 2008;7(10):927–938.
   PubMed Web of Science ®Google Scholar
• Alves G, Forsaa EB, Pedersen KF, Epidemiology of Parkinson's disease. J Neurol 2008;255(Suppl 5):18–32.
   PubMed Web of Science ®Google Scholar
• Tadaiesky MT, Dombrowski PA, Figueiredo CP, Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease. Neuroscience 2008;156(4):830–40.
   PubMed Web of Science ®Google Scholar
• Karlsgodt KH, Robleto K, Trantham-Davidson H, Reduced dysbindin expression mediates N-methyl-d-aspartate receptor hypofunction and impaired working memory performance. Biol Psychiatry 2011;69(1):28–34.
   PubMed Web of Science ®Google Scholar
• Corcoran KA, Donnan MD, Tronson NC, NMDA receptors in retrosplenial cortex are necessary for retrieval of recent and remote context fear memory. J Neurosci 2011;31(32):11655–9.
   PubMed Web of Science ®Google Scholar
• Laurie DJ, Seeburg PH. Ligand affinities at recombinant N-methyl-d-aspartate receptors depend on subunit composition. Eur J Pharmacol 1994;268:335–45.
   PubMed Web of Science ®Google Scholar
• Zhu G, Chen Y, Huang Y, MPTP-meditated hippocampal dopamine deprivation modulates synaptic transmission and activity-dependent synaptic plasticity. Toxicol Appl Pharmacol 2011;254(3):332–41.
   PubMed Web of Science ®Google Scholar
• Olivares D, Deshpande VK, Shi Y, N-methyl d-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease. Curr Alzheimer Res 2012;9(6):746–58.
   PubMed Web of Science ®Google Scholar
• Hsieh MH, Gu SL, Ho SC, Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson's rat model. Behav Brain Res 2012;229(1):41–7.
   PubMed Web of Science ®Google Scholar
• May-Simera H, Levin ED. NMDA systems in the amygdala and piriform cortex and nicotinic effects on memory function. Brain Res Cogn Brain Res 2003;17(2):475–83.
   PubMedGoogle Scholar
• Shi L, Adams MM, Long A, Spatial learning and memory deficits after whole-brain irradiation are associated with changes in NMDA receptor subunits in the hippocampus. Radiat Res 2006;166(6):892–9.
   PubMed Web of Science ®Google Scholar
• Tang J, Strafella AP. The frontostriatal circuitry and behavioral complications in PD. Parkinsonism Relat Disord Suppl 2012;1:S104–6.
   Google Scholar
• Bartels AL, Leenders KL. Brain imaging in patients with freezing of gait. Mov Disord 2008;23(Suppl 2):S461–7.
   PubMedGoogle Scholar
• Tamaru F. Disturbances in higher function in Parkinson's disease. Eur Neurol 1997;38:33–6.
   PubMed Web of Science ®Google Scholar
• Aarsland D, Brønnick K, Larsen JP, Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest Study. Neurology 2009;72(13):1121–6.
   PubMed Web of Science ®Google Scholar